VeriMomsr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) hamilelikte güvenli mi?
No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
Related ingredients
Frequently asked questions
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) hamilelikte güvenli mi?
- No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) emzirirken güvenli mi?
- No data indicating reproductive or lactation hazard, no harmonised classifications, and no mechanistic evidence for transfer into breast milk. Topically applied peptides are expected to be degraded and have negligible systemic exposure; no studies suggest transfer to breast milk or effects on nursing infants (sources searched: ECHA Annex VI, PubMed, CosIng, PubChem).
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) bebek cildi için güvenli mi?
- No toxicity or developmental data specific to infants found. Adult hazard/mechanism assessments are absent. Although dermal absorption of intact peptides is expected to be very low, infant (0–3 yr) skin has higher surface-area-to-weight and immature barrier function, so exposure score is increased by +1 to reflect potentially higher but still likely low absorption; no evidence of infant-specific adverse effects was identified (sources: PubMed, CosIng, ECHA Annex VI, PubChem).
- VeriMom sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) nasıl puanlıyor?
- VeriMom sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5)'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.